CN101768203B - 5β,6β环氧甾体化合物及其制备方法 - Google Patents
5β,6β环氧甾体化合物及其制备方法 Download PDFInfo
- Publication number
- CN101768203B CN101768203B CN2010101242669A CN201010124266A CN101768203B CN 101768203 B CN101768203 B CN 101768203B CN 2010101242669 A CN2010101242669 A CN 2010101242669A CN 201010124266 A CN201010124266 A CN 201010124266A CN 101768203 B CN101768203 B CN 101768203B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- steroidal compounds
- preparation
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 72
- 230000003637 steroidlike Effects 0.000 title claims abstract description 43
- 239000004593 Epoxy Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 20
- 239000012074 organic phase Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 12
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 12
- 239000012286 potassium permanganate Substances 0.000 claims description 10
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000001590 oxidative effect Effects 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 235000010265 sodium sulphite Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000003643 water by type Substances 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 5
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- UGWKCNDTYUOTQZ-UHFFFAOYSA-N copper;sulfuric acid Chemical compound [Cu].OS(O)(=O)=O UGWKCNDTYUOTQZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 2
- 239000011790 ferrous sulphate Substances 0.000 claims description 2
- 150000004688 heptahydrates Chemical class 0.000 claims description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract description 9
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract description 9
- 229960004845 drospirenone Drugs 0.000 abstract description 9
- 238000006735 epoxidation reaction Methods 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 description 7
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003433 contraceptive agent Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- -1 pivaloyl oxygen Chemical compound 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000002254 contraceptive effect Effects 0.000 description 2
- 150000005826 halohydrocarbons Chemical class 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 2
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- MFWFDRBPQDXFRC-LNTINUHCSA-N (z)-4-hydroxypent-3-en-2-one;vanadium Chemical compound [V].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O MFWFDRBPQDXFRC-LNTINUHCSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical group C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 0 C[*@]1OCC1=C([C@@](C1C(C)(*CC2)*3=CC3C[C@@]1O*)C2=CC(C)(CC1)CCC1O*)O Chemical compound C[*@]1OCC1=C([C@@](C1C(C)(*CC2)*3=CC3C[C@@]1O*)C2=CC(C)(CC1)CCC1O*)O 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940083712 aldosterone antagonist Drugs 0.000 description 1
- 150000007854 aminals Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001327 anti-mineralocorticoid effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000002394 mineralocorticoid antagonist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- TZMFJUDUGYTVRY-UHFFFAOYSA-N pentane-2,3-dione Chemical compound CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
Images
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101242669A CN101768203B (zh) | 2010-03-15 | 2010-03-15 | 5β,6β环氧甾体化合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101242669A CN101768203B (zh) | 2010-03-15 | 2010-03-15 | 5β,6β环氧甾体化合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101768203A CN101768203A (zh) | 2010-07-07 |
CN101768203B true CN101768203B (zh) | 2012-11-28 |
Family
ID=42501323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101242669A Active CN101768203B (zh) | 2010-03-15 | 2010-03-15 | 5β,6β环氧甾体化合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101768203B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0402466A2 (en) * | 2004-11-30 | 2006-07-28 | Richter Gedeon Vegyeszet | Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process |
CN101503455B (zh) * | 2009-03-11 | 2011-02-16 | 药源药物化学(上海)有限公司 | 一种制备屈螺酮的方法及中间体 |
-
2010
- 2010-03-15 CN CN2010101242669A patent/CN101768203B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101768203A (zh) | 2010-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0517752B1 (pt) | processo para a preparação de drospirenona | |
CN109776644B (zh) | 一种黄体酮的合成方法 | |
Lewbart et al. | Oxidation of Steroidal α-Ketols to Glyoxals with Cupric Acetate1 | |
CN1325508C (zh) | 一锅法制备泼尼松龙衍生物 | |
Glazier | Bromination with Cupric Bromide. II. 1, 2 Bromination in the Presence of an Olefinic Bond | |
EP1985621A1 (en) | Process for production of steroids | |
Kritchevsky et al. | Partial Synthesis of Compounds Related to Adrenal Cortical Hormones. XIV. Preparation of the Dihydroxyacetone Side Chain; 17α-Hydroxyprogesterone and “Substances L and P” | |
CN101434632B (zh) | 一种3α,7α-二羟基-5β-胆烷酸的制备方法 | |
Dauben et al. | Photochemistry of 9, 10-dimethyl-. DELTA. 13-hexalins and related steroids. Role of ground-state conformations in accordant processes | |
CN102558280B (zh) | 一种30-卤代桦木酸的生产方法 | |
CN101768203B (zh) | 5β,6β环氧甾体化合物及其制备方法 | |
Cambie et al. | Reactions of enol acetates with thallium (I) acetate–iodine | |
Jing et al. | Protecting group effect on the 1, 2-dehydrogenation of 19-hydroxysteroids: a highly efficient protocol for the synthesis of estrogens | |
Bernstein et al. | Steroidal Cyclic Ketals. V. Transformation Products of Adrenosterone. The Synthesis of related C19O3-Steroids | |
Cotterrell et al. | The chemistry of triterpenes and related compounds. Part XLVII. Clarification of the nature of the tetracyclic triterpene acids of elemi resin | |
Tan et al. | Oldhamine A, a novel alkaloid from Daphniphyllum oldhami | |
CN113735932B (zh) | 一种制备坎利酮的脱氢方法 | |
CN101798307B (zh) | 一种环巴胺的制备方法 | |
CN101560237A (zh) | 14β-氢-6β,7β,15β,16β-二亚甲基-3-氧代-17β-孕甾-4-烯-21,17-羧内酯及其合成方法 | |
Marson | Oxygen-directed carbocyclizations of epoxides | |
KR100446068B1 (ko) | 구굴스테론의 제조방법 | |
CN114315946A (zh) | 甾体中间体的制备方法和应用 | |
CN102399255B (zh) | 一种桦木酸的制备方法 | |
Fuhrer et al. | Conformations of the Ten‐membered Ring in 5, 10‐Secosteroids. III:(Z)‐3β‐and (Z)‐3α‐Hydroxy‐5, 10‐seco‐1 (10)‐cholesten‐5‐one Esters and (Z)‐5, 10‐seco‐1 (10)‐Cholestene‐3, 5‐dione | |
CN101318983A (zh) | 螺[(5β,6β,15β,16β-二亚甲基-雄甾-14β-氢-5,7-二烯-3-酮)-17α-2′-(1′-氧-环戊烷-5′-酮)]及其合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yin Jinyu Inventor after: Zhang Rujin Inventor after: Xie Sheng Inventor after: Wang Jinkai Inventor before: Pan Gaofeng Inventor before: Yin Jinyu Inventor before: Zhang Rujin Inventor before: He Yijun |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: PAN GAOFENG YIN JINYU ZHANG RUJIN HE YIJUN TO: YIN JINYU ZHANG RUJIN XIE SHENG WANG JINKAI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: five b, six b Epoxy steroids and their preparation methods Effective date of registration: 20210707 Granted publication date: 20121128 Pledgee: China Construction Bank Corporation Xianju sub branch Pledgor: ZHEJIANG XIANJU JUNYE PHARMACEUTICAL Co.,Ltd. Registration number: Y2021330000826 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230323 Granted publication date: 20121128 Pledgee: China Construction Bank Corporation Xianju sub branch Pledgor: ZHEJIANG XIANJU JUNYE PHARMACEUTICAL Co.,Ltd. Registration number: Y2021330000826 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: five b, six b Epoxy steroid compounds and their preparation methods Effective date of registration: 20230509 Granted publication date: 20121128 Pledgee: China Construction Bank Corporation Xianju sub branch Pledgor: ZHEJIANG XIANJU JUNYE PHARMACEUTICAL Co.,Ltd. Registration number: Y2023330000892 |